LSTA FY 2016 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35M+56.9% YoY

Gross Profit

$4M11.8% margin

Operating Income

-$31M-88.8% margin

Net Income

-$33M-92.6% margin

EPS (Diluted)

$-74.81

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$27M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$52M

Total Liabilities

$48M

Stockholders' Equity

$5M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$22M	+56.9%
Gross Profit	$4M	$2M	+78.1%
Operating Income	-$31M	-$52M	+39.2%
Net Income	-$33M	-$81M	+59.6%